Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Tomislav Omrčen

32155

Tomislav

Omrčen

izv. prof. dr. sc.

nije evidentirano
Naziv Akcije
Murgić, Jure; Jazvić, Marijana; Miletić, Marija; Prgomet Sečan, Angela; Ulamec, Monika; Vilović, Katarina; Pezelj, Ivan; Tomašković, Igor; Bokarica, Pero; Saratlija Novaković, Žana et al. Pathological downstaging, disease control and survival after neoadjuvant chemotherapy for bladder cancer in Croatia; a real-world study // Libri oncologici : Croatian journal of oncology, 51, 1. 2023. str. 73-74
Brčić, Hrvoje; Lekić, Mirela; Jazvić, Marijana; Murgić, Jure; Miletić, Marija; Prgomet Sečan, Angela; Tomašković, Igor; Hrkać, Adelina; Bokarica, Pero; Kaučić, Hrvoje et al. Stereotactic body radiation therapy in patients with advanced urothelial cancer treated with immunotherapy: early experience within croatian oncology referral network // Libri oncologici : Croatian journal of oncology, 51, 1. 2023. str. 83-84
Miletić, Marija; Brčić, Hrvoje; Prgomet Sečan, Angela; Franceschi, Dora; Šambić Penc, Mirela; Boraska Jelavić, Tihana; Murgić, Jure; Jazvić, Marijana; Komić, Dubravka; Omrčen,Tomislav et al. Dynamics of neutrophil-to-lymphocyte ratio as a biomarker of clinical response to immune checkpoint inhibitor therapy in a multicenter cohort of patients with advanced urothelial cancer within Croatian genitourinary cancer network // Libri oncologici : Croatian journal of oncology, 51, 1. 2023. str. 64-65
Prejac, Juraj; Omrčen, Tomislav; Radić, Jasna; Vrdoljak, Eduard; Frobe, Ana; Pleština, Stjepko Predicting Trifluridine/Tipiracil Treatment in Refractory Metastatic Colorectal Cancer Patients: A Multicenter Exploratory Analysis // Oncology, (2023), doi: 10.1159/000533567
Omrčen, Tomislav; Boraska Jelavić, Tihana; Komić, Dubravka Atezolizumab in patients with metastatic urothelial cancer - retrospective analysis of the treatment experience at the Department of Oncology and Radiotherapy, University Hospital of Split. // Libri oncologici : Croatian journal of oncology, 51, Supplement 1. 2023. str. 53-54
KATIĆ, ANDRIJA ; Omrčen, Tomislav ; Viculin, Jelena ; Boban, Marijo ; Hrepić, Darijo ; Vrdoljak, Eduard TREATMENT PATTERNS AND SURVIVAL OUTCOMES OF PATIENTS WITH METASTATIC GASTRIC CANCER AT THE DEPARTMENT OF ONCOLOGY AND RADIOTHERAPY, UNIVERSITY HOSPITAL OF SPLIT FROM 2018 TO 2020 - A RETROSPECTIVE ANALYSIS. // Libri oncologici : Croatian journal of oncology, 50, 1. 2022. str. 154-156
Omrčen, Tomislav SYSTEMIC TRIPLE THERAPY IN METASTATIC HORMONE SENSITIVE PROSTATE CANCER (MHSPC) // Acta clinica Croatica, 61 (2022), Supplement 3; 81-85. doi: 10.20471/acc.2022.61.s3.12
Prejac, Juraj ; Omrčen, Tomislav ; Radić, Jasna ; Vrdoljak, Eduard ; Fröbe, Ana ; Pleština, Stjepko A multicenter exploratory analysis of the possible predictive factors for trifluridine/tipiracil in refractory metastatic colorectal cancer // Annals of oncology / André, F. (ur.). 2022. str. S316-S316 doi: 10.1016/j.annonc.2022.04.276
Jović Zlatović, J. ; Bevanda, M. ; Skelin, M. ; Telesmanić Dobrić, V. ; Curić, Z. ; Marijanović, I. ; Grubisić-Čabo, F. ; Krečak, I. ; Tomić, S. ; Kralik, K. et al. P-206 Association between primary tumor site of colorectal cancer and RAS/BRAF mutational status with venous thromboembolism: A retrospective- prospective cohort study from 3 Croatian oncology centers // Annals of oncology. 2022. str. S322-S323 doi: 10.1016/j.annonc.2022.04.296
Omrčen Tomislav Non-hormonal systemic treatment of prostate cancer // Libri oncologici : Croatian journal of oncology. 2021. str. 80-80
nije evidentirano
nije evidentirano